MSB 2.70% 95.0¢ mesoblast limited

Ann: Phase 3 Trial in COVID-19 ARDS Surpasses 50% Enrollment, page-17

  1. 15,520 Posts.
    lightbulb Created with Sketch. 5593
    IMO this could see 60% enrolment surpassed by the end of October enabling two DSMB 30 day analysis's in the month of November - the 45% and the 60% ..... it is basically only 1.5 enrolments per hospital site between now and the end of October (21 days) - just sayin'

    60% analysis IMO will be when the overwhelming results will become evident enough to stop the trial altogether

    GLTAH
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
95.0¢
Change
0.025(2.70%)
Mkt cap ! $1.084B
Open High Low Value Volume
94.0¢ 96.8¢ 93.5¢ $4.207M 4.417M

Buyers (Bids)

No. Vol. Price($)
3 42268 94.0¢
 

Sellers (Offers)

Price($) Vol. No.
95.0¢ 48002 3
View Market Depth
Last trade - 16.10pm 09/08/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.